Table 5.
Findings Summary of the Patient Assessment, Disease Screening, Diagnosis, and Referring
| Country | Author | The Issue | Findings |
|---|---|---|---|
| USA | (Kherghehpoush and Kimberly, 2021)53 | HIV and HCV screening and education | Combining HIV and HCV point-of-care testing with comprehensive patient education and risk mitigation counseling could reduce transmission rates. |
| UK | (Barrett et al 2019)64 | Hypertension | Responding pharmacies were able to provide valuable BP monitoring services to their patients, though quality enhancements need to be implemented. |
| Malta | (Zammit, Rebecca, 2021)65 | BP, FBG and Cholestrol, | POCT provision for BP, BG, and lipid profiles within community pharmacies was feasible and showed improvement in test parameters at follow-ups |
| USA | (Kherghehpoush et al 2023)66 | HIV and HCV care continuum | Pharmacist referrals were made for 28 participants, and 71% were confirmed to have established regular care. |
| USA | (Klepser et al 2022)67 | HIV and HCV screening | 0.8% of HIV tests showed a reactive result, while HCV tests were 20.9%. |
| USA | (Isho et al 2017)68 | HCV screening | Pharmacist-led HCV screening services were implemented successfully at the community pharmacy and showed HCV knowledge scores improvement |